NCT01081808 Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01031212 ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01030055 Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00974896 QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00960258 Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors. Status COMPLETED Phase PHASE1
NCT00858377 A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00838201 Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00830778 Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy Status COMPLETED Phase PHASE3
NCT00821652 Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination Status COMPLETED Phase PHASE1
NCT00813384 A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00807859 Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00800865 A Study to Evaluate Biomarkers in Patients With Solid Tumors (0000-097)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00777530 Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects Status COMPLETED Phase PHASE1
NCT00770536 AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR Status COMPLETED Phase PHASE1
NCT00728793 A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00653939 A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00613652 A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients Status COMPLETED Phase PHASE1